Welcome to Alt-Support-Diabetes.org

Alt-Support-Diabetes.org is under new management.

The previous webmaster was discouraged by the lack of interest in the site, and the death of Usenet in general. The active members in the alt.support.diabetes newsgroup weren't even referring to it anymore.

The domain registration for Alt-Support-Diabetes.org was paid years in advance by Mack, who was a frequent poster on the alt.support.diabetes newsgroup and an Alt-Support-Diabetes.org Webmaster. So it doesn't make sense to have a "We're shutdown" message for the next several years. However, it's probable the site will disappear on 12 April 2024.

Some of the information here is very old as the original site was established in 2001 and much of it has never been updated. But it's still a valuable resource. So it's back.

If you would like to contribute content for the site, please contact the ASD Webmaster. Articles attributed to ASD Webmaster as contributor are those for which the true author cannot be determined. If you know who should be credited, please let us know.

Alt-Support-Diabetes (ASD) is an online support group of diabetics, their families and friends. We use this forum to freely share our personal experiences, knowledge, hopes, successes and frustrations concerning diabetes and it's impact on our lives. Currently we are using three major forums: the newsgroup alt.support.diabetes, our IRC chat room, and this website.

Newsgroups are one of the oldest parts of the internet called UseNet. It even pre-dates the World Wide Web. Currently there are over 70,000 individual newsgroups.

We encourage everyone to first read the Newsgroups FAQ. It explains the few do's and don'ts and some basic information about posting to a UseNet forum such as ours.

Disclaimer

The information made available through this web site is not intended to replace the services of a physician. It is provided for informational purposes only and is not a substitute for professional medical advice.

Diabetes News from MIT

30 May 2023

MIT news feed about: Diabetes

Diabetes News from ScienceDaily

29 May 2023

Learn about early diabetes symptoms, diabetic diet information, diabetes care, type 1 diabetes, insulin resistance and type 2 diabetes. Read the latest medical research on diabetes.
  • Scientists target human stomach cells for diabetes therapy
    Stem cells from the human stomach can be converted into cells that secrete insulin in response to rising blood sugar levels, offering a promising approach to treating diabetes, according to a preclinical study.
  • Experimental drug inhibits or prevents diabetic eye disease
    Researchers say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. The results are from a study that used mouse as well as human retinal organoids and eye cell lines.
  • Afternoon exercise linked with greater improvements in blood sugar levels for patients with type 2 diabetes
    A new study uses data from the Look AHEAD (Action for Health in Diabetes) study, a randomized controlled trial that compared an intensive lifestyle intervention with diabetes support and education in patients diagnosed with type 2 diabetes and overweight or obesity to track the development of cardiovascular disease over time.
  • Researchers map the brain during blood sugar changes
    Researchers have successfully mapped specific regions in the brain that are activated in association with changes in blood sugar -- also known as glucose -- providing fundamental location information that could ultimately lead to more targeted therapies for people who struggle with conditions like diabetes.
  • Artificial pancreas reduces disease management burden for people with diabetes
    Researchers design a novel algorithm for controlling implanted insulin pumps that accounts for the unique characteristics of individual patients. Their model, tested using an FDA-approved diabetes computer simulation, proves intraperitoneal (within the abdominal cavity) insulin delivery is fast and closely mimics natural physiological insulin delivery. They developed a model that can account for individual patient differences and validated a pump control algorithm that does not require meal announcement.